SCHEMBL22378642

SCHEMBL22378642

N#Cc1cccc(-c2cccc(-n3c4ccccc4c4ccccc43)c2)c1-c1c(C#N)cccc1-n1c2ccccc2c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GABRA1 P14867 3/20 0.36
GABRG2 P18507 3/20 0.36
GABRB3 P28472 3/20 0.36
GABRA5 P31644 3/20 0.36
GABRA3 P34903 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
HIF1A Q16665 1/20 0.35
GABRA2 P47869 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MCL1 Q07820 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP19A1 P11511 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
HTR1A P08908 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19697248 0.93 GABRG2 (0.39) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL22378661 0.93 KDM4E (0.37) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL22379362 0.93 KDM4E (0.37) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL22379042 0.92 GABRA1 (0.35) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL22379063 0.92 GABRA1 (0.35) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL22378433 0.90 KDM4E (0.37) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL19755245 0.90 KDM4E (0.41) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL22377872 0.90 GABRA1 (0.37) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL22377833 0.90 SMN1; SMN2 (0.38) KDM4EATML3MBTL1GABRA1GABRG2
SCHEMBL22377863 0.88 KDM4E (0.36) KDM4EATML3MBTL1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 KDM4E 3290/4885ATM 3429/4885L3MBTL1 1164/4885
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 KDM4E 3290/4885ATM 3429/4885L3MBTL1 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.